InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,463.60
(
0.25%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.56
(
0.52%
)
Bitcoin
65,210.99
(
1.89%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

v-man

Send PM Follow Ignore
Followers 2
Posts 80
Boards Moderated 0
Alias Born 03/14/2002

v-man

Member Level

Re: ostromjo post# 1805

Tuesday, 07/30/2002 2:54:47 PM

Tuesday, July 30, 2002 2:54:47 PM

Post# of 14671
-- BioShield Executives Receive Favorable Summary Judgment Against AHT Corporation --

/FROM PR NEWSWIRE ATLANTA 404-231-1814/
TO BUSINESS, MEDICAL AND TECHNOLOGY EDITORS:

BioShield Executives Receive Favorable Summary Judgment Against AHT
Corporation

Summary Judgment Decision by Southern District Bankruptcy Court, New York;
No Liability For Bioshield Executives

ATLANTA, July 30 /PRNewswire-FirstCall/ -- BioShield Technologies, Inc
(OTC Bulletin Board: BSTI) announced today that the United States Bankruptcy
Court for the Southern District of New York, overseeing the case of AHT
Corporation vs. BioShield Technologies, Inc., and certain directors and
officers of the Company as defendants, has awarded a summary judgment in favor
of certain officers and directors of Bioshield Technologies in a decision that
was handed down on July 16, 2002 by the Honorable Judge Hardin.
Tim Moses stated "this is phenomenal news for the executives of Bioshield
and removes a burden that has hung over our heads for over a year and a half.
We are hopeful that this will serve as a springboard to resolving the rest of
this case in the near future and moving forward with a renewed focus on
building BioShield Technologies and finally putting this distraction behind
us."
AHT still has the opportunity to seek to overturn the favorable decision
BioShield executives received. Although the final outcome of this case cannot
be determined at this time, BioShield's management believes in the potential
for favorable developments on the corporate level that will positively impact
BioShield Technologies, Inc. and its shareholders.

About Bioshield Technologies, Inc.:
BioShield Technologies, Inc., is a Norcross Georgia-based emerging growth
company focused in biotechnology and antimicrobial products. Its core
business is committed to the discovery, development, marketing and sale of
surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is a revolutionary alternative to conventional
sanitizers, disinfectants, bleaches, biocides or preservatives primarily
because it kills bacteria, including HIV, on contact and can remain active for
extended time periods. To date BioShield has received three US patents and
eight EPA registrations, including the first U.S. germ killer and disinfectant
against Salmonella cholerasuis, Staphylococcus aureus and other
microorganisms. The company has developed several alliances in different
industries, such as healthcare, textiles and storm water.
Further information on BioShield and its line of products can be found by
visiting the firm's web site at http://www.bioshield.com , or by calling
1-770-925-3653, Tim Moses.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up